The global didecyldimethylammonium chloride (DDAC) market is expected to reach US$ 998.3 Mn in 2028 and is anticipated to register CAGR of 11.2% from 2021-2028 LONDON, Oct. 12, 2021 (GLOBE NEWSWIRE) - ...
Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies Patients with HER2-positive breast cancer were treated on two trials: ddAC ...
Enhertu plus THP improved pCR rates in HER2-positive early breast cancer compared to ddAC-THP, with notable benefits in hormone receptor-positive and negative populations. The DESTINY-Breast11 trial ...
* 2 pts not restaged after ddAC excluded. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results